Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05287217 · ClinicalTrials.gov registry record · NA
Post-operative Pain Control With Acetaminophen and Ibuprofen After Functional Endoscopic Sinus Surgery
A NA study, sponsored by University of Illinois at Chicago.
- Terminated
- Registry status
- NA
- Development phase
- 60
- Enrollment target
NCT05287217 is a NA study that was terminated before completion, run by University of Illinois at Chicago. The registered enrollment target is 60 participants.
The verdict
NCT05287217, a NA study, was terminated before completion, sponsored by University of Illinois at Chicago.
- TERMINATED
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
Study Summary
The safest and most effective post-operative pain control regimen after functional endoscopic sinus surgery (FESS) has been the subject of persistent research. This prospective study will compare post-operative pain control when managed either by a defined medication schedule or medication taken on an as-needed basis after functional endoscopic sinus surgery for chronic rhinosinusitis. Prior to surgery, patients will be randomly selected to be in one of two treatment arms. One group will receive instructions to take specific medications (acetaminophen and ibuprofen on a specific schedule post-operatively. The second treatment groups will be instructed to take the same medications but on an as needed basis for pain. Patients will also be provided with an option of a limited supply of narcotic analgesics for pain should they be needed. Post-operative pain control will be assessed by the patient with a pain-diary documenting perceived levels of pain for 10 days post-operatively using a validated visual analog scale. At the conclusion of the study the records of medications taken along with pain responses will be compared between groups
Interventions
- OTHER Comparison of medication administration for pain control
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2022-07-29 |
| Est. Completion | 2023-06-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05287217
The ClinicalTrials.gov registry entry for NCT05287217 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Illinois at Chicago, which has 430 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Comparison of medication administration for pain control is the first listed.
NCT05287217 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05287217 about?
NCT05287217 is a clinical study titled "Post-operative Pain Control With Acetaminophen and Ibuprofen After Functional Endoscopic Sinus Surgery". The safest and most effective post-operative pain control regimen after functional endoscopic sinus surgery (FESS) has been the subject of persistent research. This prospective study will compare post-operative pain control when managed either by a defined medication schedule or medication taken on ...
What is the current status of trial NCT05287217?
This trial is currently terminated. It is a NA study. The enrollment target is 60 participants. The study started on 2022-07-29. Estimated completion is 2023-06-30.
What interventions are being tested in trial NCT05287217?
The interventions under investigation include: Comparison of medication administration for pain control (OTHER).
Who is sponsoring clinical trial NCT05287217?
This trial is sponsored by University of Illinois at Chicago, which has 430 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.